Global Animal Health
Global Animal Health is a Dubai-based value-added distributor of veterinary biologicals, pharmaceuticals, feed additives, nutritional supplements, and diagnostic tools, serving clinics, farms, and veterinary professionals across the Middle East and North Africa with a multi-species, multi-principal portfolio.
- Company typePrivate
- Founded-
- HeadquartersDubai, United Arab Emirates
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Global Animal Health does
Global Animal Health is a Dubai, UAE-based value-added distributor of animal health products serving the Middle East and North Africa (MENA) region. The company supplies biologicals, pharmaceuticals, feed additives, nutritional supplements, and diagnostic tools to veterinary professionals, veterinary clinics, pet shops, farms, and stables. Its portfolio is organized across species categories that include equine, camel, cattle, poultry, sheep and goats, companion animals, and pigeons — a mix that reflects both commercial livestock segments and regionally distinctive categories such as camel and racing pigeons.
The business operates on a multi-principal distribution model, sourcing products from international manufacturers and supplying them through its MENA network. Named principals include Fujita Pharmaceutical (Japan), NovaVive, Kyotobiken, Pharmagal Bio, and Colorado Serum, indicating a deliberate strategy of diversifying supply across North America, Europe, and Asia. The company is family-owned and private, with a headcount of approximately nine employees, consistent with a focused specialty distribution profile rather than a generalist or large wholesaler operation.
Beyond physical logistics, the distributor appears to provide regulatory affairs services to its principals, evidenced by country-specific product registrations such as the Kyotobiken product registration in Egypt in December 2020. This combination of regional distribution coverage, multi-species product breadth, country-level regulatory navigation, and a multi-origin principal base forms the core of Global Animal Health's value proposition to both suppliers and end-customers in the MENA animal health market.
Global Animal Health firmographics
Firmographics- Name
- Global Animal Health
- Legal name
- Global Animal Health
- Website
- https://global-ah.net
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Global Animal Health is a Dubai-based value-added distributor of veterinary biologicals, pharmaceuticals, feed additives, nutritional supplements, and diagnostic tools, serving clinics, farms, and veterinary professionals across the Middle East and North Africa with a multi-species, multi-principal portfolio.
- Ownership category
- akta.pro rank
Global Animal Health industry classification
Industry- Product category
- Animal Health Distribution
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)
- akta.pro secondary industries
- Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns) (HLAMAIAG)
Keywords
Where Global Animal Health is headquartered
LocationHeadquarters
- HQ city
- Dubai
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
Global Animal Health business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Product Distribution: Revenue is generated through the import and distribution of animal health biologicals, pharmaceuticals, feed additives, nutritional supplements, and diagnostic products to veterinary professionals across Middle East and North Africa. The company acts as a value-added distributor, providing not only products but also solutions adapted to each species, along with technical support and cold chain delivery.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Global Animal Health product offering
Product offeringCore offering
Global Animal Health is a value-added distributor of animal health products for the MENA region. The company imports and distributes veterinary biologicals (vaccines), pharmaceuticals (antibiotics, antimicrobials, anti-parasitics, anti-coccidials, tonics), feed additives, nutritional supplements and diagnostic tools from international manufacturers — principally Fujita Pharmaceutical Co., Ltd. of Japan — supplying veterinarians, livestock and poultry producers, aquaculture operations, and pet-care retailers.
Product overview
Global Animal Health is a value-added distributor of animal health biologicals, pharmaceuticals, feed additives, nutritional supplements, equipment, and diagnostic products for food-producing and companion animals across the Middle East and North Africa. The company operates as a solution provider rather than a single product, offering an integrated portfolio organized by species: Equine (including vaccines, respiratory, reproductive, locomotion, and athletic products like EQUIMUNE, SETTLE, RELIEF GEL, TOTAL LACTIC CARE), Camel (antiparasitics like G-TRYPAN, rumen stimulants, locomotion products), Cattle (respiratory vaccines like CattleWin-5K and Bovi Sera, reproductive products like ESTROGAL, antiparasitics like DELMAX POUR-ON, Amplimune immunostimulant), Poultry (vaccines including AVIGAL series, PESTIPHARM, BURSIPHARM, BRONCHIPHARM, and feed supplements like COXSAN, LICOROL, PROTECT Ox for coccidiosis, heat stress and respiratory support), Companion Animals/Dogs & Cats (vaccines PRO-VAC DHPPL, PRO-VAC RABIES-Fc, antiparasitics GALCES), Sheep & Goats (vaccines POLIOVIN, Case-Bac, Clostridium antitoxin, electrolytes), and Pigeons (vaccines DIFTOVAC, SALMOVAC, PHARMAVAC COLUMBI2, COLUMBA for pox, salmonella, and paramyxovirus). The company also provides diagnostic tools including FTE cards and diagnostic kits, and supports cold chain distribution and good distribution practices.
Differentiator
Problem solved
Functional benefit
Products and services
- DIFTOVAC
Quantifiable outcome
- Amplimune shown to improve fertility by 68.6% reduction in clinical mastitis and 27.2% reduction in metritis in dairy cows (Colorado State University study)
Companies that use Global Animal Health
Customer profileSegments4 records
Ideal customer profiles1 record
Global Animal Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Global Animal Health partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Fujita Pharmaceutical Co., Ltd.coreMay 2023 partnership with Fujita Pharmaceutical Co., Ltd. (Japan), affiliate of Sasaeah Pharmaceutical Co., Ltd. The collaboration aims to bring innovative and high-quality pharmaceutical solutions made in Japan to the Middle East and North Africa region.
- NovaVive Inc.coreNovaVive Inc. is an animal health immunobiology company. Amplimune (mycobacterium cell wall fraction immunostimulant) is distributed by Global Animal Health. Amplimune is approved in USA, Canada, New Zealand and UAE to reduce clinical signs and mortality associated with E. coli K99 diarrhea in neonatal calves.
- KyotobikencoreKyotobiken Co., Ltd. - Japanese animal health company. Two bovine vaccines (CATTLENWIN-5k for bovine respiratory diseases and BOVINE EPHEMERAL FEVER VACCINE) registered in Egypt through this partnership.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Global Animal Health competitors and assessment
Company assessmentBroad incumbents
- Vetoquinol: Global animal health pharmaceutical company with a significant MENA footprint and direct distribution in the region. Comparable because it distributes veterinary pharmaceuticals and biologics across multiple species, though at a much larger scale and with proprietary products.
- Ceva Santé Animale: Major French animal health company with strong presence in poultry, swine, and ruminant vaccines across MENA. Comparable because it supplies many of the same manufacturers Global Animal Health distributes for and serves the same veterinary professional customer base in the region.
- Zoetis: World's largest animal health company with a regional presence in MENA covering companion animals, livestock, and poultry. It is a competitor for the same end-customer wallet and an alternative distributor choice for manufacturers.
- Virbac: Global animal health company with a meaningful presence in MENA across companion animals, livestock, and aquaculture. It competes for the same veterinary professional customer in UAE, Saudi Arabia, and Egypt.
Direct peers
- Phileo (Lesaffre): Animal health and nutrition division of Lesaffre specializing in yeast and bacteria-based products. A partner supplier of Global Animal Health and comparable in commercial overlap on feed additives and supplements in MENA.
- Kyotobiken: Japanese animal health vaccine manufacturer of the CATTLENWIN-5K and Bovine Ephemeral Fever vaccines registered in Egypt through Global Animal Health. Comparable as a partner manufacturer whose success in MENA depends on GAH's distribution.
- Pharmagal Bio: Slovak animal health biologicals and pharmaceuticals manufacturer. A direct supplier of Global Animal Health and comparable as a small European animal health company exporting to MENA via regional distributors.
- MEVET: Spanish animal health manufacturer that is itself a partner supplier of Global Animal Health. Comparable as a Spain-based veterinary biologics/pharmaceuticals producer targeting MENA and similar distribution-led market entry models.
Emerging players
- Fujita Pharmaceutical Co., Ltd. Japanese pharmaceutical affiliate of Sasaeah Pharmaceutical Group that partnered with Global Animal Health in May 2023 to enter MENA. Comparable as a Japan-based manufacturer using regional distribution to access MENA veterinary channels.
Regional players
- Al Hikma Pharmaceuticals (Al-Hikma Vet): Regional MENA pharmaceutical and veterinary products distributor. Comparable as a local/regional animal health distributor that competes with Global Animal Health for veterinary channel access in the Gulf and Levant.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Global Animal Health social profiles
Digital presenceGlobal Animal Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Animal Health leadership team
Management profileNumber of profiles
Global Animal Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Animal Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Animal Health
What does Global Animal Health do?
Global Animal Health is a value-added distributor of animal health products for the MENA region. The company imports and distributes veterinary biologicals (vaccines), pharmaceuticals (antibiotics, antimicrobials, anti-parasitics, anti-coccidials, tonics), feed additives, nutritional supplements and diagnostic tools from international manufacturers — principally Fujita Pharmaceutical Co., Ltd. of Japan — supplying veterinarians, livestock and poultry producers, aquaculture operations, and pet-care retailers.
Is Global Animal Health a public or private company?
Global Animal Health is a private company. It is classified as family owned and is currently operating.
When was Global Animal Health founded?
Global Animal Health was founded in -1. It employs 1 to 10 people.
Where is Global Animal Health based?
Global Animal Health is headquartered in Dubai, United Arab Emirates, in the Middle East region.
How does Global Animal Health make money?
One revenue line is on record: product Distribution.
Who are Global Animal Health's main competitors?
Broad incumbents on record are Vetoquinol, Ceva Santé Animale, Zoetis and Virbac. Direct peers are Phileo (Lesaffre), Kyotobiken, Pharmagal Bio and MEVET. Fujita Pharmaceutical Co., Ltd. is listed as an emerging player. Al Hikma Pharmaceuticals (Al-Hikma Vet) is listed as a regional player.
Does Global Animal Health have an API?
No public API is recorded for Global Animal Health.
What industry is Global Animal Health in?
Global Animal Health's product category is Animal Health Distribution. Its primary akta.pro industry code is HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors, with a secondary code of HLAMAIAC, Veterinary Vaccine & Biologics Distributors. Its SIC code is 5047.